Thermo Scientific Pierce Protease and Phosphatase Inhibitor Mini Tablets, EDTA-free, contain both protease inhibitors and phosphatase inhibitors to provide broad-spectrum complete protection from dephosphorylation and proteolytic degradation.
Features of Protease and Phosphatase Inhibitor Mini Tablets, EDTA-free: ? Improved formulation—tablets dissolve quickly to form a clear solution ? Economical—more cost effective than other commercially available formulations for equivalent volumes ? Convenient—ready-to-use, fully disclosed, broad-spectrum formulations ? Compatible—use directly with Pierce BCA assays ? EDTA-free—formulated without EDTA, a metalloproteinase inhibitor (only for EDTA-free formulations)
The Pierce Protease and Phosphatase Inhibitor Mini Tablets contain aprotinin, bestatin, E-64, and leupeptin to provide protection from degradation by serine proteases, cysteine proteases, and aspartic acid proteases. To prevent the dephosphorylation activity of serine/threonine and tyrosine phosphatases, each tablet also contains sodium fluoride, sodium orthovanadate, sodium pyrophosphate, and beta-glycerophosphate. Pierce Protease and Phosphatase Inhibitor Tablets are stable at 4°C for up to 12 months, and each tablet is sufficient for 10 mL of solution.
2